Pfizer, BioNTech start testing Omicron vaccine

From Reuters.

Pfizer and BioNTech said they started a clinical trial to test a new version of their vaccine specifically designed to target the COVID-19 Omicron variant

#News #Reuters #Pfizer #BioNTech #Omicron

Subscribe: http://smarturl.it/reuterssubscribe

Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.

Get the latest news on: http://reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en